Applied Clinical Trials Named Jesse H. Neal National Business Journalism Award Finalist
Applied Clinical Trials has been honored by American Business Media as a finalist in the 57th Annual Jesse H. Neal National Business Journalism Awards competition for editorial excellence. Applied Clinical Trials is one of 123 finalists selected by a distinguished board of judges for its Clinical Trial Insights column, written by Kenneth Getz, MBA, Senior Research Fellow at Tufts CSDD and Chairman of CISCRP.
The judging panel, chaired by Abe Peck of Northwestern University’s Medill School of Journalism, selected the finalists from an original pool of 660 entries. The winners will be announced on March 10 during ABM’s annual Neal Awards ceremony at the Mandarin Oriental in New York City.
Paying tribute to the Neal Award finalists, American Business Media President & CEO Clark Pettit said, “We at ABM are so proud to honor these journalists and editors. Their expertise, ability to push progress across existing and new channels, and successful track records of informing the industry on important issues place them at the forefront of their fields.”
Established in 1955, the Jesse H. Neal National Business Journalism Awards recognize and reward editorial excellence in business media. The awards are named after American Business Media’s first managing director who remained active in promoting the industry throughout his life. The Neal Awards are presented annually to those editors who have submitted entries exhibiting journalistic enterprise, service to the field and editorial craftsmanship.
Entries are divided into three classifications according to the publication’s advertising and circulation revenue, with 12 editorial categories within each size classification and seven categories that do not require revenue figures. Material must have been published between December 1, 2009, and November 30, 2010.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
